Key facts
| Price (PPV) | 230 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | lopromide |
| Class | Contrast media |
| ATC code | V08AB05 |
| Manufacturer | BAYER S.A |
| Presentation | Flacon de 50 ml |
| Nature | Médicament |
| Hospital price | 144.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Le médicament ne doit être utilisé qu'à des fins diagnostiques. Ultravist 150 Angiographie intra-artérielle avec soustraction digitale, contrôle fonctionnel d'un shunt d'hémodialyse. Ultravist 240, 300, 370 Renforcement du contraste dans la tomodensitométrie (TDM), angiographie avec soustraction digitale, urographie intraveineuse, phlébographie des membres, visualisation des cavités de l'organisme (p.ex. arthrographie, fistulographie) à l'exception de la myélographie, ventriculographie, cisternographie. Ultravist 240: Également indiqué pour l'hystérosalpingographie. Ultravist 300: Également indiqué pour la vénographie, l'artériographie et l'hystérosalpingographie. Ultravist 370: Également indiqué pour l'angiocardiographie. Source : Compendium.ch - Date : 21 octobre 2025
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Ultravist 370 mg / ml (BAYER S.A) contains the same active substance as Ultravist 370 mg / ml (Lopromide) at the same strength, but in a different pack: Flacon de 100 ml at 434 MAD, i.e. 4.34 MAD per ml against 4.60 MAD for Ultravist 370 mg / ml. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Ultravist 370 mg / ml | BAYER S.A | Flacon de 100 ml | 434 MAD | 4.34 / ml |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Ultravist 370 mg / ml
Ultravist 370 mg / ml belongs to the contrast media therapeutic class. In Morocco, this drug is marketed by BAYER S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ultravist 370 mg / ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ultravist 370 mg / ml
Answers to common questions from Moroccan patients about this drug.